Skip to content

Open House Biologika Rabattverträge 2026-24 - Aflibercept (ATC: S01LA05; Wirkstärke: 40 mg/ml)

open

Techniker Krankenkasse

Read the notice at vergabe-de ↗

Value
unstated
Published
17 Nov 2026
Deadline
31 Dec 2026, 22:58 GMT · 40d left · as published, verify on the notice
Type
opportunity
33600000 · Medical equipment, pharmaceuticals & personal careDE600

Description

Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130a Abs. 8 SGB V zu dem Wirkstoff Aflibercept (ATC: S01LA05; Wirkstärke: 40 mg/ml) zu schließen.

Key facts

Reference
OH-Biologika-2026-24
Procedure
open
Lots
1
Contact
DZEM@tk.de
+49 4069094-040
Bids opened
31 Dec 2026, 22:59 GMT
Regime
publicSector
  • The documents — every attachment, with its text extracted and searchable
  • Qualification — the notice scored against your company profile
  • Tracking and alerts — a pipeline for your bids, and the matching notices by email
  • Calendar export — the deadline as a calendar file
  • The API and MCP — the same record in your own tools and your AI assistant

Provenance

Source
vergabe-de
Notice id
c0fdd64e-c55a-41af-ae79-f9f9207cae85
OCID
ocds-mnwr74-70109477-82db-4403-b21a-4a5481722f56
First seen
22 Nov 2026
Last updated
22 Nov 2026

Licence CC0 1.0 public domain dedication ↗

Source: Bekanntmachungsservice (oeffentlichevergabe.de), Beschaffungsamt des BMI — CC0 1.0.

View at source ↗GET /api/v1/tenders/0e34459c-1c97-487a-9b11-540354e17142

The source notice is authoritative — verify deadlines and documents there before bidding.